This is a summary of the European public assessment report (EPAR). It explains how the Committee for Medicinal Products for Human Use (CHMP) assessed the studies performed, to reach its recommendations on how to use the medicine. If you need more information about your medical condition or your treatment, read the package leaflet (also part of the EPAR) or contact your doctor or pharmacist. If you want more information on the basis of the CHMP recommendations, read the scientific discussion (also part of the EPAR).
Therapeutic Indication
### Therapeutic indication Treatment of a haemodynamically significant patent ductus arteriosus in preterm newborn infants less than 34 weeks of gestational age.
Therapeutic Area (MeSH)
N/AATC Code
C01EB16
ATC Item
ibuprofen
Pharmacotherapeutic Group
Cardiac therapy
Active Substance (Summary)
INN / Common Names
N/A| Substance | CAS | Monograph |
|---|---|---|
| Ibuprofen | N/A | 布洛芬 |
EMA Name
Pedea
Medicine Name
Pedea
Aliases
N/ANo risk management plan link.
